The Life Sciences Innovative Ma

Application Components: Expression of Interest; application forms; financial and project documentation; panel interview; due diligence documentation

Application Platform: Expression of Interest (EOI) followed by application process via LSIMF portal

Decision Process: Multi-stage process including EOI screening, health resilience assessment, panel interview, financial and economic assessment, and due diligence

Funding Structure: Grants typically cover 10–20% of project costs (maximum 25%); minimum project size £8 million

important notes: Applications are assessed in quarterly rounds; funding subject to subsidy control rules; projects must be UK-based and capital investment focused; annual review of scheme may change criteria and timelines

Ineligible Costs: Projects related to veterinary medicine, herbal medicines, nutritional supplements, raw ingredients, standalone consumables, and secondary packaging

Key Organisational Requirements: Must be a UK-registered company or establishment; must provide audited accounts or evidence of funding; must demonstrate manufacturing capability or product development track record

Match Funding Requirement: Applicants must fund the remaining project costs (grant typically covers 10–20%, up to a maximum of 25%)

Objectives: To increase UK health resilience and create economic growth through investment in life sciences manufacturing capacity and capability